Bristol-Myers exec appointments
Charles Heimbold, Jr., former senior vice-president, promoted to exec VP with continued responsibility for company's Consumer Products Group, Health Care Group and its Planning and Development divisions; Michael Autera, former senior VP, to exec-VP, retaining present administrative responsibilities including duties as chief financial officer; Stephen Carter, MD, to president, Pharmaceutical Research and Development Division; Jerome Birnbaum, PhD, to exec-VP for research, Pharmaceutical Research and Development Division.
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.